Yu Yong 4
4 · GENELUX Corp · Filed Dec 18, 2023
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
VP, Clinical Trial Operations
Transactions
- Sale
Common Stock
2023-12-15$14.18/sh−5,803$82,265→ 0 total - Sale
Common Stock
2023-12-15$12.94/sh−26,732$345,915→ 5,803 total
Footnotes (2)
- [F1]The weighted average sale price for the transaction reported was $12.9401, and the range of prices were between $12.69 and $13.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]The weighted average sale price for the transaction reported was $14.1763, and the range of prices were between $13.80 and $14.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.